National Bank of Canada’s Nymox Pharmaceutical Corp NYMX Stock Holding History

National Bank of Canada’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,200	Closed	-$3.27K	–	2952
2023 Q2	$3.27K	Hold	17,200	–	–	﹤0.01%	2415
2023 Q1	$5.85K	Hold	17,200	–	–	﹤0.01%	2258
2022 Q4	$5.05K	Hold	17,200	–	–	﹤0.01%	2334
2022 Q3	$7K	Hold	17,200	–	–	﹤0.01%	2289
2022 Q2	$7K	Hold	17,200	–	–	﹤0.01%	2360
2022 Q1	$21K	Hold	17,200	–	–	﹤0.01%	2171
2021 Q4	$22K	Buy	+17,200	New	+$27.4K	﹤0.01%	2150

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

National Bank of Canada's NYMX Position: Q3 2023 in Review

National Bank of Canada sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 17,200 shares — an estimated $3.27K sold.

National Bank of Canada first reported a position in NYMX in Q4 2021 and held it in 7 quarters. The position peaked at $22K in Q4 2021. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

National Bank of Canada reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
National Bank of Canada sold 17,200 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $3.27K.
National Bank of Canada first reported a position in Nymox Pharmaceutical Corp in Q4 2021 and held it in 7 quarters.
National Bank of Canada's Nymox Pharmaceutical Corp position peaked at $22K in Q4 2021.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.